Kiora Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Capital Stock (Details)

Capital Stock (Details)										1 Months Ended						12 Months Ended
Capital Stock (Details)	Aug. 07, 2023 USD ($) shares	Aug. 05, 2023 day $ / shares	Jun. 06, 2023 USD ($) $ / shares shares	Feb. 22, 2023 USD ($) shares	Feb. 10, 2023 USD ($) shares	Feb. 03, 2023 USD ($) $ / shares shares	Nov. 17, 2022 USD ($) $ / shares shares	Jul. 26, 2022 USD ($) $ / shares shares	Jun. 18, 2022 shares	Nov. 30, 2023 USD ($) shares	Aug. 31, 2023 shares	Jul. 31, 2023 shares	Jun. 30, 2023 shares	Apr. 30, 2023 USD ($) shares	Feb. 28, 2023 shares	Dec. 31, 2023 USD ($) shares	Dec. 31, 2022 USD ($) shares
Class of Stock [Line Items]
Net proceeds from sale \| $			$ 5,600,000
Underwriting discount and commissions \| $			500,000
Underwriting expenses \| $			$ 200,000
Exercise price (in usd per share) \| $ / shares								$ 8.00
Proceeds from warrant exercise and sale \| $							$ 3,100,000
Placement agent transaction fees, equal to percentage of gross proceeds from sale							8.00%
Proceeds from exercise of warrants \| $										$ 8,600						$ 307,079	$ 520,000
Proceeds from private placement, net of issuance costs \| $																115,715	0
Warrants outstanding (in shares)	11,500,000
Deemed dividends from warrant reset provision \| $	$ 500,000															$ 530,985	$ 0
Lincoln Park
Class of Stock [Line Items]
Proceeds from issuance of common stock, net of offering costs \| $				$ 100,000										$ 300,000
Common Stock
Class of Stock [Line Items]
Issuance of Panoptes holdback shares (in shares)																	10,087
Issuance of shares of common stock from warrant exercises (in shares)																66,400	65,000
Class A Warrant
Class of Stock [Line Items]
Warrants exercised (in shares)							654,609
Inducement Warrant
Class of Stock [Line Items]
Exercise price (in usd per share) \| $ / shares							$ 5.97
Period from issuance that warrant becomes exercisable							6 months
Warrants and rights outstanding, term							18 months
Class C Warrant
Class of Stock [Line Items]
Issuance of shares of common stock from warrant exercises (in shares)					50,000					8,200					50,000
Proceeds from exercise of warrants \| $					$ 300,000
Class D Warrants
Class of Stock [Line Items]
Issuance of shares of common stock from warrant exercises (in shares)										8,200
Public Offering
Class of Stock [Line Items]
Public offering price (in usd per share) \| $ / shares								8.00
Shares issued, price per preferred share, five thousand Class A warrants and five thousand Class B warrants (in usd per share) \| $ / shares								$ 1,000
Net proceeds from sale \| $								$ 5,300,000
Underwriting discount and commissions \| $								400,000
Underwriting expenses \| $								$ 300,000
Proceeds from issuance of common stock, net of offering costs \| $																$ 5,595,962	$ 5,377,719
Public Offering \| Common Stock
Class of Stock [Line Items]
Issuance of Stock (in shares)																2,197,628	592,392
Public Offering \| Class A Warrant
Class of Stock [Line Items]
Number of warrants issued to purchase the shares (in shares)								30,095,697
Number of warrants considered for determination of public offering price of preferred shares issued with warrants (in shares)								5,000
Public Offering \| Class A Warrants, Exercise of Option
Class of Stock [Line Items]
Number of warrants issued to purchase the shares (in shares)								3,925,525
Public Offering \| Class B Warrant
Class of Stock [Line Items]
Number of warrants issued to purchase the shares (in shares)								30,095,697
Number of warrants considered for determination of public offering price of preferred shares issued with warrants (in shares)								5,000
Public Offering \| Class B Warrant, Exercise Of Option
Class of Stock [Line Items]
Number of warrants issued to purchase the shares (in shares)								3,925,525
Public Offering \| Class C Warrant
Class of Stock [Line Items]
Number of warrants issued to purchase the shares (in shares)			5,750,000
Public Offering \| Class D Warrants
Class of Stock [Line Items]
Number of warrants issued to purchase the shares (in shares)			5,750,000
Public Offering \| Class C and Class D Warrants
Class of Stock [Line Items]
Exercise price (in usd per share) \| $ / shares		$ 0.5231	$ 1.10
Warrants exercise price reduction, trading day period immediately following initial exercise day \| day		60
Warrant exercise price reduction percentage of average of the volume weighted average price for trading day period immediately prior to reset date		90.00%
Warrants exercise price reduction, trading day period immediately prior to reset date \| day		5
Private Placement
Class of Stock [Line Items]
Issuance of Stock (in shares)						52,798
Number of warrants issued to purchase the shares (in shares)						105,596
Warrants and rights outstanding, term						5 years
Proceeds from private placement, net of issuance costs \| $						$ 100,000
Warrants exercisable, anniversary of closing date						6 months
Private Placement \| Common Stock
Class of Stock [Line Items]
Exercise price (in usd per share) \| $ / shares						$ 3.538
Private Placement \| Common Stock
Class of Stock [Line Items]
Issuance of Stock (in shares)																52,798
Over-Allotment Option \| Class C Warrants, Exercise Option
Class of Stock [Line Items]
Number of warrants issued to purchase the shares (in shares)			750,000
Over-Allotment Option \| Class D Warrants, Exercise Option
Class of Stock [Line Items]
Number of warrants issued to purchase the shares (in shares)			750,000
Common Shares
Class of Stock [Line Items]
Number of warrants issued to purchase the shares (in shares)								98,138
Common Shares \| Public Offering
Class of Stock [Line Items]
Issuance of Stock (in shares)								592,392
Number of warrants issued to purchase the shares (in shares)								160,000
Number of securities called by each warrant or right (in shares)								40
Warrants convertible into common stock (in shares)								1,504,785
Series E Convertible Preferred Stock \| Public Offering
Class of Stock [Line Items]
Number of shares issued upon conversion (in shares)								1,280
Common Stock
Class of Stock [Line Items]
Number of shares issued upon conversion (in shares)											481,770	481,770	2,688,822
Common Stock \| Lincoln Park
Class of Stock [Line Items]
Issuance of Stock (in shares)				20,000										105,000
Equity line of credit (up to) \| $						$ 10,000,000
Common Stock \| Inducement Warrant
Class of Stock [Line Items]
Number of warrants issued to purchase the shares (in shares)							654,609
Common Stock \| Public Offering
Class of Stock [Line Items]
Issuance of Stock (in shares)			2,197,628
Number of warrants issued to purchase the shares (in shares)			3,552,372
Common Stock \| Over-Allotment Option
Class of Stock [Line Items]
Number of warrants issued to purchase the shares (in shares)			750,000
Series F Convertible Preferred Stock
Class of Stock [Line Items]
Conversion of stock, shares converted (in shares)											530	530	2,958
Series F Convertible Preferred Stock \| Public Offering
Class of Stock [Line Items]
Number of shares issued upon conversion (in shares)			3,908
Series F Convertible Preferred Stock \| Public Offering \| 909 Class C and 909 Class D Warrants
Class of Stock [Line Items]
Purchase price (in usd per share) \| $ / shares			$ 999.90
Panoptes Pharma Ges .m.b.h.
Class of Stock [Line Items]
Issuance of Panoptes holdback shares (in shares)									10,087
Holdback shares, term									18 months